These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...

Researchers have discovered a new approach to prostate cancer treatment by combining immunotherapy with PIM1 kinase ...

Fluorescence navigation is a novel technique for accurately identifying hepatocellular carcinoma (HCC) lesions during hepatectomy, enabling real-time visualization. Indocyanine green-based ...

(PDCs) demonstrate tumor-selective delivery and potent anticancer activityPreclinical data show robust efficacy as ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

(UroToday.com) The 2025 APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and ...

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

This condition usually gets worse slowly as the number of blood cells goes up. MDS/MPNs are rare blood cancers that have features of both myelodysplastic disorders and myeloproliferative neoplasms: ...

In the mouse model and human tumor samples, MAGE-4 drives the accumulation of plasma immune cells that suppress antitumor immunity. The study points at novel potential therapeutic avenues that could ...

DelveInsight’s Blastic Plasmacytoid Dendritic Cell Neoplasm Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES ...